BIOVASCULAR

biovascular-logo

BioVascular is a clinical stage privately held biotechnology company developing “first in class” products for platelet mediated cardiovascular diseases. BioVascular’s initial product, saratin, is a polypeptide produced by recombinant means in yeast. This product was discovered by and licensed from Merck KGaA. BioVascular is conducting human clinical trials of saratin for use in hemodialysis access graft and peripheral artery grafts to reduce intimal hyperplasia, which can lead to failure of the graft.

#People #Financial #Website #More

BIOVASCULAR

Industry:
Biotechnology Health Diagnostics Medical

Founded:
2006-01-01

Address:
San Diego, California, United States

Country:
United States

Website Url:
http://www.biovascularinc.com

Total Employee:
1+

Status:
Active

Contact:
858-455-5000

Email Addresses:
[email protected]

Total Funding:
10.87 M USD

Technology used in webpage:
Nginx GoDaddy SSL Shockwave Flash Embed Nginx 1.16 Intermedia Media Temple MediaTemple DNS



Current Advisors List

martin-münchbach_image

Martin Münchbach Board of Directors @ BioVascular
Board_member

Investors List

bb-biotech-ventures_image

BB Biotech Ventures

BB Biotech Ventures investment in Series C - BioVascular

domain-associates_image

Domain Associates

Domain Associates investment in Series C - BioVascular

merck-kgaa_image

Merck

Merck investment in Series C - BioVascular

Official Site Inspections

http://www.biovascularinc.com

  • Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
  • IP address: 15.197.148.33
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "BioVascular"

BioVascular - Crunchbase Company Profile & Funding

Contact Email [email protected] Phone Number 858-455-5000 BioVascular is a clinical stage privately held biotechnology company developing “first in class†products for …See details»

BioVascular Company Profile 2024: Valuation, Funding …

Information on valuation, funding, cap tables, investors, and executives for BioVascular. Use the PitchBook Platform to explore the full profile.See details»

BioVascular Inc Overview | SignalHire Company Profile

Organization Website: biovascularinc.com : Social Links: Phone Number: 858-455-5000: BioVascular Inc industries Pharma: BioVascular Inc Employees Size 1-10 employees: DMA …See details»

BioVascular, Inc. - VentureRadar

Novel cardiovascular therapeutics ... Find out more about BioVascular, Inc., Biotechnology, Healthtech and Life Sciences, DNA, RNA, Peptide Therapies and .See details»

BioVascular - Overview, News & Similar companies - ZoomInfo

BioVascular contact info: Phone number: (858) 455-5000 Website: www.biovascularinc.com What does BioVascular do? BioVascular Inc. is a privately held biotechnology company that …See details»

BioVascular Inc overview - services, products, equipment data and …

Biovascularinc.com. San Diego, California, United States (858) 455-5000 [email protected] linkedin. BioVascular Inc. BioVascular is a clinical stage privately held biotechnology company …See details»

BioVascular Inc - Company Profile and News - Bloomberg Markets

Company profile page for BioVascular Inc including stock price, company news, executives, board members, and contact informationSee details»

Biovascular - Products, Competitors, Financials, Employees ...

Humacyte Announces Allowance of U.S. Patent Covering BioVascular Pancreas (BVP™) Sep 19, 2024 - New U.S. patent covers the design and composition of the BVP - - Positive results from …See details»

BioVascular Inc. (San Diego, California) - Wikimapia

BioVascular Inc. 12230 El Camino Real, Suite 100 San Diego, California 92130 (858) 455-5000 voice (858) 455-6200 fax [email protected] http://www.biovascularinc ...See details»

BioVascular Inc. - BioCentury Company Profiles - BCIQ

Oct 15, 2007 BioVascular Inc. - BioCentury Company Profiles for the biopharma industrySee details»

BioVascular - Funding, Financials, Valuation & Investors

How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Feb 7, 2008: Series C - …See details»

Synovis Life Technologies - Wikipedia

Synovis Life Technologies is a Minneapolis-based manufacturer of various medical devices.The company appeared on the 2004 edition of Fortune 100 Fastest Growing Companies, a …See details»

BioVascular Inc. - San Diego, California (CA) - BiosciRegister

Profile: BioVascular Inc. is a biotechnology company that develops drugs & devices for the control of intimal hyperplasia associated with vascular procedures and control of risk factors …See details»

BioVascular Inc Overview - Salary.com

Discover essential details about BioVascular Inc, including address, contact, and journey of our company's evolution.See details»

BioVascular’s Competitors, Revenue, Number of Employees

Mar 11, 2018 BioVascular’s Profile, Revenue and Employees. BioVascular, is to develop and commercialize novel cardiovascular therapeutics for significant unmet medical needs. …See details»

BioVascular | EquityNet

BioVascular is a clinical stage privately held biotechnology company developing first in class products for platelet mediated cardiovascular diseases. BioVasculars initial product, saratin, is …See details»

BioVascular Inc. :: Scrip

Oct 1, 2007 BioVascular is a beneficiary of Merck KGAA's incubator program. launched to encourage start-up companies to develop Merck's shelved technologies. BioVascular gained …See details»

BioVascular, Inc. Merges with Revitus and Acquires First-In

SAN DIEGO, Sept. 10 /PRNewswire/ -- BioVascular, Inc., a company focused on developing therapies targeting platelet-mediated diseases, today announced that it has merged with …See details»

BioVascular Inc. Closes $10.87 Million Series C Financing

Feb 8, 2008 BioVascular Inc. Closes $10.87 Million Series C Financing SAN DIEGO, Feb. 7 -- BioVascular Inc., a company focused on developing therapies targeting platelet-mediated …See details»

BioVascular, Inc. Expands Executive Team | BioSpace

SAN DIEGO, Feb. 26 /PRNewswire/ -- BioVascular, Inc., a company focused on developing novel therapies targeting platelet-mediated diseases, today announced that it appointed Christopher …See details»

linkstock.net © 2022. All rights reserved